Risk of malignancy with long-term immunosuppression in renal transplant recipients
- 1 July 2004
- journal article
- Published by Elsevier in Kidney International
- Vol. 66 (1) , 383-389
- https://doi.org/10.1111/j.1523-1755.2004.00741.x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipients1Transplantation, 2003
- Incidence and clinical course of de-novo malignancies in renal allograft recipientsEuropean Journal of Surgical Oncology, 2001
- Cancer incidence in a kidney-transplanted populationTransplant International, 2000
- Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996New England Journal of Medicine, 2000
- Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Transplantation, and Recipients of a First Cadaveric TransplantNew England Journal of Medicine, 1999
- Posttransplant malignanciesTransplantation Proceedings, 1999
- Lymphoma incidence, cyclosporine, and the evolution and major impact of malignancy following organ transplantationTransplantation Proceedings, 1997
- Malignancy after renal transplantation: Analysis of incidence and risk factors in 1700 patients followed during a 25-Year periodTransplantation Proceedings, 1997
- MALIGNANT DISEASE IN PATIENTS WITH LONG-TERM RENAL TRANSPLANTSTransplantation, 1995
- Increased Incidence of Lymphoproliferative Disorder after Immunosuppression with the Monoclonal Antibody OKT3 in Cardiac-Transplant RecipientsNew England Journal of Medicine, 1990